| 000 | 01189 a2200337 4500 | ||
|---|---|---|---|
| 005 | 20250513195155.0 | ||
| 264 | 0 | _c19991130 | |
| 008 | 199911s 0 0 eng d | ||
| 022 | _a0149-2918 | ||
| 024 | 7 |
_a10.1016/S0149-2918(99)80044-7 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aShaw, L M | |
| 245 | 0 | 0 |
_aCurrent opinions on therapeutic drug monitoring of immunosuppressive drugs. _h[electronic resource] |
| 260 |
_bClinical therapeutics _cOct 1999 |
||
| 300 |
_a1632-52; discussion 1631 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aCyclosporine _xblood |
| 650 | 0 | 4 | _aDrug Monitoring |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImmunoassay |
| 650 | 0 | 4 |
_aImmunosuppressive Agents _xblood |
| 650 | 0 | 4 |
_aMycophenolic Acid _xanalogs & derivatives |
| 650 | 0 | 4 |
_aSirolimus _xblood |
| 650 | 0 | 4 |
_aTacrolimus _xblood |
| 700 | 1 | _aHolt, D W | |
| 700 | 1 | _aKeown, P | |
| 700 | 1 | _aVenkataramanan, R | |
| 700 | 1 | _aYatscoff, R W | |
| 773 | 0 |
_tClinical therapeutics _gvol. 21 _gno. 10 _gp. 1632-52; discussion 1631 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/S0149-2918(99)80044-7 _zAvailable from publisher's website |
| 999 |
_c10522843 _d10522843 |
||